ESMO 2019 | The Pitfalls of cell-free DNA sequencing

Geoffrey Oxnard

Geoffrey Oxnard, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the downfalls of the use of cell-free DNA in the detection of cancer at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter